Lancet
-
Multicenter Study
Perioperative covert stroke in patients undergoing non-cardiac surgery (NeuroVISION): a prospective cohort study.
The importance...
The growth in procedural medicine has seen increasing numbers of older patients undergoing surgery, with significant concern for the unproven potential of surgery and anaesthesia to hasten cognitive decline. Perioperative stroke is a major adverse event with high mortality (32%) and morbidity (59%) with cognitive consequences.
The NeuroVISION investigators sought to quantify the burden of covert stroke, that is stroke without overt symptoms.
What did they do?
The researchers conducted a multi-center prospective cohort study of 1,114 patients ≥65 years having elective non-cardiac, non-intracranial, non-carotid surgery. All patients underwent post-operative MRI to identify cerebral infarction, and 1 year follow-up to quantify cognitive decline.
And they found?
7% of patients showed MRI features of covert stroke. Of these 42% demonstrated cognitive decline at 1 year, compared to 29% of those without covert stroke (OR CI 1.22-3.20). There were associations with delirium (HR CI 1.06-4.73) and symptomatic stroke or TIA (HR CI 1.14-14.99).
Thus covert stroke is relatively common in this cohort of patients, and is associated with cognitive decline. Notably there was no associated increase in non-neurological outcomes or death, nor association with anaesthetic technique.
Hang on...
Although covert stroke was associated with greater incidence of cognitive decline, the later was still common among non-stroke patients (almost 30%), and around 25% of all patients showed MRI evidence of old chronic infarcts. Additionally because there was no non-surgical control, it is difficult to implicate surgery and anaesthesia itself as a precipitant of the covert strokes (compared with the disease process requiring surgery, or comorbidity).
Perhaps the greater take-home is that in an elderly population with significant morbidity (64% HT, 44% smokers, 27% DM) both stroke (chronic, covert and overt) and cognitive decline are not uncommon.
And the big question
Are any of these stroke related outcomes actually modifiable perioperatively? To meaningfully improve perioperative outcomes, there must be an available improvement in anaesthetic technique, surgical technique or triaging, or postoperative care.
It is likely that the greatest impact is still to be made through primary health care and not perioperative interventions.
summary -
Randomized Controlled Trial Multicenter Study
Oral antihypertensive regimens (nifedipine retard, labetalol, and methyldopa) for management of severe hypertension in pregnancy: an open-label, randomised controlled trial.
Hypertension is the most common medical disorder in pregnancy, complicating one in ten pregnancies. Treatment of severely increased blood pressure is widely recommended to reduce the risk for maternal complications. Regimens for the acute treatment of severe hypertension typically include intravenous medications. Although effective, these drugs require venous access and careful fetal monitoring and might not be feasible in busy or low-resource environments. We therefore aimed to compare the efficacy and safety of three oral drugs, labetalol, nifedipine retard, and methyldopa for the management of severe hypertension in pregnancy. ⋯ PREEMPT (University of British Columbia, Vancouver, BC, Canada; grantee of Bill & Melinda Gates Foundation).